Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 26,272
Sort by:

Fungal Pneumonia - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Fungal Pneumonia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histo...

January 2022 60 pages

Fungal Pneumonia - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Fungal Pneumonia- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understan...

January 2022 200 pages

G Protein-Coupled Receptor (GPCR) - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'G Protein-Coupled Receptor (GPCR) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of t...

January 2022 60 pages

GABA Receptor Antagonist - Pipeline Insight, 2022

US$ 1,250.00

This report can be delivered to the clients within 48 hrs “GABA Receptor Antagonist - Pipeline Insight, 2022” report by DelveInsight offers comprehensive insights of the pipeline (under development)...

January 2022 60 pages

Galactosemia - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Galactosemia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historica...

January 2022 60 pages

Gastric Neuroendocrine Tumors - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gastric Neuroendocrine Tumors - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the d...

January 2022 60 pages

Gastric Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Gastric Neuroendocrine Tumors- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-de...

January 2022 200 pages

Gastro Intestinal Bleeding - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gastro Intestinal Bleeding - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dise...

January 2022 60 pages

Gastro Intestinal Bleeding - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Gastro Intestinal Bleeding- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth...

January 2022 200 pages

Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) - Epidemiology Forecast to 2032' report delivers an in-de...

January 2022 60 pages

Gastroesophageal Adenocarcinoma - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Gastroesophageal Adenocarcinoma- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-...

January 2022 200 pages

Gastroesophgeal adenocarcinoma -Epidemiology Forecast -2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gastroesophgeal adenocarcinoma - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the...

January 2022 60 pages

Gastrointestinal Cancer - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gastrointestinal Cancer - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease...

January 2022 60 pages

Gaucher disease Type 1 - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gaucher disease Type 1 - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...

January 2022 60 pages

Gender dysphoria - Epidemiology Insight - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gender dysphoria - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histo...

January 2022 60 pages

Gene and Cell Therapies in Rare Disorder - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gene and Cell Therapies in Rare Disorder - Epidemiology Forecast to 2032' report delivers an in-depth understandi...

January 2022 60 pages

Gene And Cell Therapies In Rare Disorder - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Gene And Cell Therapies In Rare Disorder- Market Insights, Epidemiology, and Market Forecast-2032' report delive...

January 2022 200 pages

Gene and Cell Therapies targeting CNS disorders - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gene and Cell Therapies targeting CNS disorders - Epidemiology Forecast to 2032' report delivers an in-depth unde...

January 2022 60 pages

Gene and Cell Therapies Targeting CNS Disorders - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Gene and Cell Therapies Targeting CNS Disorders- Market Insights, Epidemiology, and Market Forecast-2032' report...

January 2022 200 pages

Gene Therapies for Cardiomyopathies - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gene Therapies for Cardiomyopathies - Epidemiology Forecast to 2032' report delivers an in-depth understanding of...

January 2022 60 pages

Gene Therapies for Cardiomyopathies - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Gene Therapies for Cardiomyopathies- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an...

January 2022 200 pages

Gene Therapy for Ocular Rare Disease - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gene Therapy for Ocular Rare Disease - Epidemiology Forecast to 2032' report delivers an in-depth understanding o...

January 2022 60 pages

Gene therapy in rare diseases - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gene therapy in rare diseases - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the d...

January 2022 60 pages

General Anxiety Disorder (GAD) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'General Anxiety Disorder (GAD) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the...

January 2022 60 pages

Generalized Anxiety Disorder - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Generalized Anxiety Disorder - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the di...

January 2022 60 pages

Generalized Myasthenia Gravis (gMG) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Generalized Myasthenia Gravis (gMG) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of...

January 2022 60 pages

Generalized pustular psoriasis - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Generalized pustular psoriasis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the...

January 2022 60 pages

Generalized Pustular Psoriasis - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Generalized Pustular Psoriasis- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-d...

January 2022 200 pages

Geographic Atrophy (GA) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Geographic Atrophy (GA) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease...

January 2022 60 pages

Germ Cell Tumor - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Germ Cell Tumor- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understand...

January 2022 200 pages

Germany Healthcare Outlook Report, 2022

US$ 1,995.00

This report can be delivered to the clients within 24 Hours DelveInsight’s, “Germany Healthcare Outlook 2022,” report provides comprehensive insights about healthcare scenario, regulatory policies a...

January 2022 60 pages

Gestational Diabetes - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Gestational Diabetes- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth under...

January 2022 200 pages

Ghrelin receptor agonists - Pipeline Insight, 2022

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Ghrelin Receptor Agonist - Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies and 5+ pipel...

January 2022 60 pages

Giant Axonal Neuropathy (GAN)- Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Giant Axonal Neuropathy (GAN) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the d...

January 2022 60 pages

Giant Axonal Neuropathy (GAN) - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Giant Axonal Neuropathy (GAN)- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-de...

January 2022 200 pages

Giant-Cell Arteritis - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Giant-Cell Arteritis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, h...

January 2022 60 pages

Giant Cell Arteritis (GCA) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Giant Cell Arteritis (GCA) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dise...

January 2022 60 pages

Giant Papillary Conjunctivitis - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Giant Papillary Conjunctivitis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the...

January 2022 60 pages

Giant Papillary Conjunctivitis - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Giant Papillary Conjunctivitis- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-d...

January 2022 200 pages

Gigantism - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gigantism - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical a...

January 2022 60 pages

Glioblastoma - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Glioblastoma - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historica...

January 2022 60 pages

Glioblastoma - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Glioblastoma- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding...

January 2022 200 pages

Gliosarcoma - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gliosarcoma - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical...

January 2022 60 pages

Global Kinase Inhibitor in Autoimmune Diseases - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Global Kinase Inhibitor in Autoimmune Diseases - Epidemiology Forecast to 2032' report delivers an in-depth under...

January 2022 60 pages

Global Kinase Inhibitor in Autoimmune Diseases - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Global Kinase Inhibitor in Autoimmune Diseases- Market Insights, Epidemiology, and Market Forecast-2032' report...

January 2022 200 pages

Global Messenger RNA - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Global Messenger RNA - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, h...

January 2022 60 pages

Global Messenger RNA - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Global Messenger RNA- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth under...

January 2022 200 pages

Glomerulonephritis - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Glomerulonephritis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, his...

January 2022 60 pages

Glomerulonephritis - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Glomerulonephritis- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth underst...

January 2022 200 pages

Glucocorticoid receptor antagonists - Pipeline Insight, 2022

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Glucocorticoid Receptor Antagonist - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies a...

January 2022 60 pages

Filters

Search

Categories

116
13,920
10,876
311
72
977

Publishers

72
1
322
469
292
33
4
1,872
635
92
3,109
8
109
111
554
7
55
5
5
6
23
18
23
205
30
34
6,128
13
12
142
363
8
25
84
385
8
14
49
179
7
2,002
139
579
2,786
7
24
44
31
54
61
7
2,538
40
34
11
22
16
38
2
4
83
4
26
50
1
139
11
118
36
20
61
32
50
33
27
32
42
326
877
49
88
80
59
37
2
14
22
2

Regions

8
7
7
7
7
7
7
6
6
5
3
2
2
1
1
1
247
59
50
48
47
46
42
27
22
22
19
18
17
16
15
15
15
14
14
14
14
14
14
13
13
13
13
13
13
13
13
13
13
13
13
12
12
12
12
11
11
11
11
11
10
10
10
10
10
9
9
9
7
6
6
5
183
13
12
8
431
234
125
56
49
33
29
8
7
6
6
6
6
6
5
5
5
4
3
3
5
5
5
4
3
1
1
1
1
1
2
2
77
23,670

Price

—

Date

—

Pages

—

Offers

44
5
1